N.J.S.A. 26:2L-3 — Definitions

26:2L-3. Definitions As used in this act: a. "Board" means the Therapeutic Research Qualification Review Board established in section 5 of this act. b. "Commissioner" means the State Commissioner of Health. c. "Schedule I controlled dangerous substance" means a controlled dangerous substance having a high addiction liability; no accepted medical use in the United States; and listed in New Jersey Administrative Code 8:65-10.1. d. "Drugs" means drugs as defined in section 2 of P.L.1970, c. 226 (C. 24:21-2). e. "Practitioner" means a physician licensed to prescribe and administer drugs which are subject to the "New Jersey Controlled Dangerous Substances Act" (P.L.1970, c. 226). f. "Program" means the controlled dangerous substances therapeutic research program established in this act. L.1981, c. 72, s. 3, eff. March 23, 1981.

This is the verbatim text of N.J.S.A. 26:2L-3, retrieved from the New Jersey Legislature's public statute corpus. Statutes are amended periodically — for the most current version, check the external source link above. Kyzer is not a law firm and this page is not legal advice.